Heart Failure (Pediatric): Clinical Trials

2 recruiting, 1 not yet recruiting. 3 Phase 3.

By phase and status

Phase	Trials	Status
Phase 3	3	Recruiting 2, Not yet recruiting 1

Follow Heart Failure (Pediatric): new trials by email Literature Review of Heart Failure (Pediatric) trials Research Report on Heart Failure (Pediatric)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Clinical Trial of a MEK Inhibitor for RASopathy-Associated Severe Infantile Hypertrophic Cardiomyopathy: Baby MERIT Trametinib - HCM, Noonan Syndrome and Other Rasopathy	Phase 3	Not yet recruiting	Carelon Research	25	2027-08-01	2026-09-14
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction Finerenone (Kerendia, BAY94-8862) - Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)	Phase 3	Recruiting	Bayer	117	2026-06-01	2026-10-27
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction Finerenone (Kerendia, BAY94-8862), Placebo - Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric)	Phase 3	Recruiting	Bayer	111	2025-11-19	2026-10-15

Narrower conditions

Heart Failure (3)  ·  Ventricular Dysfunction, Left (2)  ·  Noonan Syndrome (1)

Broader conditions

Cardiovascular Diseases (3)  ·  Heart Diseases (3)  ·  Ventricular Dysfunction (2)  ·  Cardiovascular Abnormalities (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Connective Tissue Diseases (1)  ·  Craniofacial Abnormalities (1)  ·  Heart Defects, Congenital (1)  ·  Musculoskeletal Abnormalities (1)  ·  Musculoskeletal Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

finerenone (2)  ·  trametinib (1)

Sponsors

Bayer (2)  ·  Carelon Research (1)

Countries

Argentina (2)  ·  Austria (2)  ·  Belgium (2)  ·  Brazil (2)  ·  Bulgaria (2)  ·  Canada (2)  ·  Czechia (2)  ·  Finland (2)  ·  Germany (2)  ·  Greece (2)  ·  Hungary (2)  ·  Israel (2)  ·  Italy (2)  ·  Mexico (2)  ·  Poland (2)